Clinical Trial Update: Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating allopregnanolone for Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile X-associated Tremor Ataxia Syndrome

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Randi J. Hagerman, MD | Conditions: Fragile X-associated Tremor/Ataxia Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-12-06